Nanotein Technologies, Inc. logo

Nanotein Technologies, Inc.

2 Marks
Corp.
First Filed:Jan 20, 2023Latest Filed:Jan 20, 2023Address:2950 San Pablo Ave, Berkeley, CA 94702

Portfolio Overview

Registered
2(100%)

Top Classes

Class 5
Pharmaceuticals
2(100%)
Class 1
Industrial Chemicals & Adhesives
2(100%)

TTAB Proceedings

No litigation activity

Top Firms

LEVINE BAGADE HAN LLP(Jan 2023)
2

Trademark Portfolio

2 results

(current & previous marks)

Refine by Mark/Description🔽
Filed
Registered
Last Activity
NANOSPARK
NANOSPARK
Trademark
Word
REGISTERED
Owner:
Serial:97763098
Filed:Jan 20, 2023
Classes:1, 5
Registration:7314331
Registered:Feb 27, 2024
Goods & Services
Cell therapy reagents for use in vitro for medical use; biopharmaceuticals, namely, engineered protein arrays, polypeptides, and macromolecular complexes being protein arrays for use in vitro for medical use, namely, the treatment of cancer; biopharmaceuticals, namely, self-assembling protein-based nanoparticles for use in vitro for medical use, namely, the treatment of cancer; T-cell activator being reagents for use in vitro for medical use; Cell therapy reagents for use in medical and scientific research and for use in the manufacture of cell therapy biopharmaceuticals in vitro; engineered protein arrays, polypeptides, and macromolecular complexes being protein arrays for use in medical and scientific research in vitro and for use in the manufacture of cell therapy biopharmaceuticals in vitro; self-assembling protein-based nanoparticles for use in medical and scientific research and for use in the manufacture of cell therapy biopharmaceuticals in vitro; T-cell activator in the nature of cell culture media for use in medical and scientific research and for use in the manufacture of cell therapy biopharmaceuticals in vitro
NANOTEIN TECHNOLOGIES
REGISTERED
Owner:
Serial:97763089
Filed:Jan 20, 2023
Classes:1, 5
Registration:7314330
Registered:Feb 27, 2024
Goods & Services
Cell therapy reagents for use in vitro for medical use; biopharmaceuticals, namely, engineered protein arrays, polypeptides, and macromolecular complexes being protein arrays for use in vitro for medical use, namely, the treatment of cancer; biopharmaceuticals, namely, self-assembling protein-based nanoparticles for use in vitro for medical use, namely, the treatment of cancer; T-cell activator being reagents for use in vitro for medical use; Cell therapy reagents for use in medical and scientific research and for use in the manufacture of cell therapy biopharmaceuticals in vitro; engineered protein arrays, polypeptides, and macromolecular complexes being protein arrays for use in medical and scientific research in vitro and for use in the manufacture of cell therapy biopharmaceuticals in vitro; self-assembling protein-based nanoparticles for use in medical and scientific research and for use in the manufacture of cell therapy biopharmaceuticals in vitro; T-cell activator in the nature of cell culture media for use in medical and scientific research and for use in the manufacture of cell therapy biopharmaceuticals in vitro; "TECHNOLOGIES"

Cookie Preferences

We use cookies (including Google Analytics) to improve our site and understand how visitors use it.